Driving immunometabolism to control lung infection

When drugs to kill microbes are ineffective, host-directed therapy uses the body’s own immune system to deal with the infection. This approach is being tested in patients with COVID-19, and now a team of researchers at Trinity College Dublin has published a study showing how it might also work in the fight against tuberculosis (TB). The findings are published in […]

» Read more

Q&A: The importance of effective population health data management

According to a survey commissioned by Sage Growth Partners, over 50% of leaders are underwhelmed by population health management technology as they say their current population solution doesn’t meet their needs. This has highlighted a pressing need for effective analytics and data to be embedded in population health solutions, particularly amidst the coronavirus pandemic. Professor Mahmood Adil, provides expertise in […]

» Read more

Glenmark’s Favipiravir drug shows encouraging results in Phase 3 clinical trial

Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where Covid-19 patients administered with Favipiravir reported faster clinical cure and viral clearance as compared to Covid-19 patients (mild to moderate) with routine care. The company said that patients randomised to Favipiravir treatment arm reported faster […]

» Read more

Researchers discover new pathways that could help treat RNA viruses

Researchers at the University of New Hampshire have identified new pathways in an RNA-based virus where inhibitors, like medical treatments, unbind. The finding could be beneficial in understanding how these inhibitors react and potentially help develop a new generation of drugs to target viruses with high death rates, like HIV-1, Zika, Ebola and SARS-CoV2, the virus that causes COVID-19. “When […]

» Read more

Scientists race to develop an effective COVID-19 vaccine

With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don’t all agree on how to get there and what “effective” really means. Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, spoke with researchers, doctors and business leaders to shed light […]

» Read more

Random testing in Indiana shows COVID-19 is 6 times deadlier than flu, and 2.8% of the state has been infected

Since day one of the coronavirus pandemic, the U.S. has not had enough tests. Faced with this shortage, medical professionals used what tests they had on people with the worst symptoms or whose occupations put them at high risk for infection. People who were less sick or asymptomatic did not get tested. Because of this, many infected people in the […]

» Read more

COVID-19: Extreme brain damage even in mild cases, Naturopathy, naturopathic specialist portal

How dangerous COVID-19 for the brain? The Coronavirus can be triggered as late extreme damage to the brain and Central nervous system effects, even in mild cases of the disease. Here, further research is urgently needed to understand the long-term consequences of COVID-19 better. In the case of a current investigation with the participation of the University College London, it […]

» Read more

Female circumcision: why bans are no panacea

On 13 July 2020, Sudan’s transitional government made a major announcement about female circumcision. Not only will the government ban the practice, but it will mandate prison terms for those who perform it. Hailed by the international community as a major step forward and a victory for women’s and girls’ rights, this move appears to be a ‘no brainer’ in […]

» Read more
1 1,678 1,679 1,680 1,681 1,682 1,813